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Recent advances in liquid chromatography-mass 
spectrometry (LC-MS) technology have led to newer 
approaches for measuring changes in peptide/protein 
abundances. Label-free LC-MS methods have been 
used for extraction of quantitative information and for 
detection of differentially abundant peptides/proteins. 
However, difference detection by analysis of data 
derived from label-free LC-MS methods requires 
various preprocessing steps including alignment, 
baseline correction, filtering, noise reduction, peak 
detection, normalization, and peak quantification. 
Although several specialized tools have been 
developed to analyze LC-MS data, determining the 
most appropriate computational pipeline remains 
challenging partly due to lack of established gold 
standards. In this paper, we use a spike-in experiment 
to evaluate the performance of three software tools in 
accurately detecting changes in peptide abundances 
from LC-MS data obtained by a label-free LC-MS 
method. We observe that tools that incorporate peptide 
isotope cluster and multiple charge information lead to 




Liquid chromatography-mass spectrometry (LC-
MS) has been an indispensable tool for profiling 
peptide/protein expression, mainly because it is a 
sensitive technique that can detect minute differences 
in peptide/protein levels [1-4]. The changes in 
peptide/protein abundances are important for 
biomarker discovery research as they are generated in 
response to a perturbation, disease, morphogenesis, 
toxicity, or any other kind of cell stress, in a given 
system. A typical LC-MS proteomics run separates 
peptides/proteins on a chromatographic column to 
elute them later, for which mass spectra are 
subsequently acquired using a mass spectrometer. 
Spectral information is acquired at a specific scan rate 
(every few seconds). Each chromatographic time point 
records a series of mass signals. These mass signals 
(m/z values) at different chromatographic time points 
are then formatted as a matrix that describes the LC-
MS data.  
Difference detection between LC-MS runs is 
achieved by either using isotope-labeled internal 





7] or a label-free approach. Although labeling methods 
have been reliably used for obtaining both relative and 
absolute quantification, certain limitations exist 
including limited number of samples that can be 
analyzed, occurrence of artifacts from labeling, limited 
measurements, limited availability of isotope 
references, extensive procedural steps, and lack of 
tools to analyze data from different platforms [8-9]. As 
a result, a growing interest is seen in the direction of 
label-free methods for biomarker discovery studies.  
Label-free methods offer an alternative strategy for 
measuring differential protein expression as they do 
not require mixing of samples and yield a wider 
dynamic range. These methods are more attractive as 
they are cost effective and involve simpler protocols. 
Several label-free difference detection methods 
exist including spectral count [10], sequence coverage 
[11], peptide count [12], and precursor signal intensity 
[13-17]. The first three methods provide relative 
abundance information based on MS/MS 
fragmentation. However, these methods tend to discard 
low abundant ions that are not typically selected for 
MS/MS fragmentation. Alternatively, a direct 
comparison method, where all ions at survey scan 
(MS1) level are analyzed, is used to capture low 
abundant ions. However, this approach requires that 
preprocessing steps such as alignment, peak detection, 
and normalization are appropriately handled. 
Various software tools exist for LC-MS data 
analysis including MZmine 2 [18], XCMS [19] and 
Progenesis LC-MS (NonLinear Dynamics, United 
Kingdom). With the increase in demand for label-free 
quantification tools, a suite of software packages have 
also been developed such as OpenMS, msInspect, 
SpecArray, SuperHirn, Xalign, and MSView [20]. 
Although many tools are available for LC-MS data 
preprocessing, they either have been optimized for 
certain platforms or have their own computational 
requirements, or challenges on how the data should be 
processed. Each tool implements a different set of 
algorithms in its workflow characterized by its set of 
strengths and limitations. While some workflows 
perform well on data preprocessing steps, others focus 
primarily on statistical and machine learning methods 
for difference detection or visualization. The spike-in 
experiment presented in this paper allows us to 
evaluate such workflows. Fig. 1 illustrates the 
experimental design that involves two groups of 
samples: (i) serum samples with spike-in peptides, and 
(ii) serum samples alone. We generated LC-MS data 
using the Qstar Elite mass spectrometer equipped with 
nano-ionization source, connected to a nano-Acquity 
UPLC system. We use our LC-MS data to evaluate 
workflows implemented in three software tools 
(Progenesis LC-MS, XCMS, and MZmine 2). All of 
them provide modular workflows which enables us to 






 Blood was collected from five healthy individuals 
in a sterile tube and allowed to clot for 30 minutes. 
Serum (clear liquid) was collected in a sterile tube after 
centrifugation at 1000 rpm for 15 minutes. Serum was 
aliquot and stored at -80°C. Serum was allowed to 
thaw at room temperature prior to analysis. 
 
2.2. Protein depletion and digestion 
 
Abundant proteins such as albumin obscure separation, 
detection and quantification of low abundant proteins 
in serum. It is common to deplete serum of high 
abundant proteins such that low abundant proteins can 
be easily detected. For our study, we depleted 60 µl of 
human serum of IgG and Albumin using Aurum serum 
protein mini columns as described in BioRad protocol 
(http://www3.bio-
rad.com/LifeScience/pdf/Bulletin_2823.pdf). Depleted 
serum was collected as the unbound eluate by 
centrifuging the column at 10,000g. Protein 
concentration was determined by Bradford assay. After 
acetone precipitation, 100 µg of depleted serum was 
set for trypsin digestion. Samples were reduced with 
50 mM tris (2-carboxyethyl) phosphine (TCEP) at 
60°C for 60 minutes. After cooling to room 
temperature, the sample was alkylated using 0.2 mM 
methyl methanethiosulfonate (MMTS) at 37°C for 30 
minutes. Trypsin was added (protein:enzyme ratio of 
50:1), followed by incubation at 37°C for 3 hrs. 
Another dose of trypsin was added after 3 hrs and the 
mixture incubated at 37°C overnight. The digested 
samples were cleaned and speed vac dried and 
reconstituted in mobile phase A solvent (0.1% formic 
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Fig. 1. Spike-in experiment to evaluate analysis of LC-
MS data generated by a label-free LC-MS method. 
 
2.3. LC-MS data acquisition 
 
Two datasets were generated from five serum 
samples obtained from five healthy individuals. The 
first dataset was derived from the five serum samples 
mixed with known concentration of spike-in peptides. 
The second dataset was obtained from the five serum 
samples alone. In the first dataset, nine MassPrep 
peptides (designated as Peptides 1-9 in Table 1) were 
added prior to acquisition of LC-MS data (Fig. 1). The 
concentration of the MassPrep peptides (1 pmol/µl) 
was selected based on best detection of the lowest 
concentration of MassPrep peptides available on the 
Qstar instrument (data not shown). Both datasets were 
acquired by LC-MS/MS on the hybrid Q-TOF mass 
spectrometer using the same acquisition parameters.  
Mass spectrometer was calibrated and nano-UPLC 
system equilibrated for optimal separation. 
Chromatographic separation was performed on a 
Waters Acquity BEH C18 column (75 µm X 150 mm, 
1.7 µm particle size) equilibrated with 98% mobile 
phase A (0.1% formic acid in H2O, 2% ACN) and 2% 
mobile phase B (0.1% formic acid in acetonitrile, 2% 
H2O). The protein digest was preloaded on a 
nanoACQUITY UPLC Symmetry C18 trap column 
(180 µm X 20 mm) before separation. Both column 
and the autosampler were maintained at a temperature 
of 40°C and 4°C respectively.  
A 180 minute linear gradient elution was performed 
as follows: 99% mobile phase A for the first 
20 minutes, changing to 20% A by 200 minutes, 15 
minutes with 1% A and finally back to 99% A for 
25 minutes at 300nL per minute flow rate. The nano-
Acquity UPLC system (Water, USA) was connected to 
a hybrid QStar-Elite MS equipped with a nano-
electrospray ionization source (Waters Micromass, 
USA) for ESI-QTOF analysis of serum samples. The 
automated system ensured reproducible loading of 
samples using LC-autosampler. MS settings were as 
follows: Ionspray voltage (IS) 2300, Interface heater 
temperature (IHT) 160°C for the positive ionization 
mode, with a mass error tolerance set to100mDa. 
Analyst (v 2.0) was used for data acquisition and LC-
MS operations.  
A full mass scan (MS1) was obtained between 
~9,000-12,000 resolution. The total scan cycle was 7 
seconds long which included one MS scan from 350-
2000 m/z and MS/MS scans for the five most intense 
product ions ranging from 50 to 2000 m/z using 30 
seconds dynamic exclusion and rolling collision energy 
for fragmentation. The dynamic exclusion feature 
enables exclusion of ions that have been selected in the 
previous scan for MS/MS from being selected again 
for that period of time. Each sample was followed with 
four wash cycles to minimize sample carryover.  
A 100 fmol E.coli beta-galactosidase digest was 
run at the beginning and end of a batch to monitor LC-
MS profiles. It was observed that due to low intensity 
of spike-in peptides when mixed in serum, no MS/MS 
information would be available. Therefore, all samples 
were acquired using an inclusion list for spike-in 
peptides. For each set, an inclusion list was prepared 
based on one injection of Massprep peptides typically 
run at the beginning of a batch, acquired under 
information dependent acquisition (IDA) mode. Only 
peptides identified with a >10% confidence interval 
were retained on the list. This file was imported into 
the Inclusion tab of the IDA method in Analyst 
software. Both a time filter of ±1 minute and the 
predicted ion m/z value was entered in the inclusion 
list. 
The data were searched against the International 
Protein Index (IPI, human v 3.6) database using 
Paragon Algorithm in ProteinPilot
TM
 software (v 3.0). 
Fixed modification was set to carboxymethyl (C) and 
variable modification to oxidation of methionine (M). 
Trypsin digestion with cysteine alkylation and ESI-Q-
TOF instrument was chosen for the searched. An 
unused score of 1.32 (equivalent to 95% confidence) 
was used on Paragon for protein identification. For 
Progenesis LC-MS software, MASCOT search was 
done against a custom MassPrep database (MPDB), 
containing MassPrep peptides and human protein 
sequences with MassPrep sequence similarity. Both 
groups: with and without spike-in peptides were 
searched against MPDB. Compiling a custom MPDB 
was necessary as some MassPrep peptides were not 
present in human database and it reduced our database 
search time considerably.  
 
2.4. Analytical tools 
 
We evaluated three software tools: Progenesis LC-
MS (NonLinear), XCMS and MZmine 2. All tools 
perform the common steps including peak detection, 
peak grouping, alignment, and difference detection. In 
addition, Progenesis LC-MS allows peptide 
identification by analysis of tandem MS (MS/MS) data. 
Both Progenesis LC-MS and MZmine 2 provide 
solutions to identify charge states and isotopic patterns. 
We observed that the identification of these patterns 
greatly reduces ambiguous comparisons and improves 
the performance of the overall workflow. 
Progenesis LC-MS generates an aggregate run 
containing the peptide ions from all analyzed runs. 
Semi-supervised alignment is achieved by choosing a 
reference run and aligning all runs to it based on 
landmark vectors (selected manually or automatically). 
The isotopic patterns are then identified. Irrelevant 
features can be further filtered out by selecting range of 
interest and charge state. For our analysis, since most 
of the peptides eluted before 150 minutes, the LC-MS 
map is filtered to retain features with only +2, +3 and 
+4 charges and within 150 minutes of gradient. Once 
filtered the data are normalized by calculating 
quantitative abundance ratio between the run being 
normalized and the reference run. Normalization is 
based on the assumption that most proteins do not 
change, and so the quantitative abundance ratio should 
be close to 1. This is followed by aggregating runs for 
difference detection and statistical analysis. 
XCMS provides a series of LC-MS data 
preprocessing algorithms implemented in R language 
and is helpful to assess performance at each 
preprocessing step. The peak detection is performed on 
overlaid extracted ion chromatograms by a pattern 
matching approach, with kernel of Gaussian or second 
derivative of Gaussian. After peak detection, peaks that 
fall within a pre-defined range are grouped together 
and better grouped peaks are identified as “well-
behaved” peaks for alignment purpose. Alignment is 
preceded by applying medium filter and local 
regressor. Since XCMS was developed for 
metabolomics study, several issues related to 
proteomics study such as charge state selection and 
isotopic pattern identification are not addressed.  
A similar workflow composed of peak detection, 
peak list deisotoping, alignment, peak row filtering and 
gap filling is carried out in MZmine 2. The peak 
detection is performed on each scan and only peaks 
which span a certain range are retained. The main 
difference between this workflow and XCMS is the 
deisotoping step which significantly eliminates 
irrelevant features.  
 
3. Results and Discussion 
 
The raw LC-MS data were exported as wiff files and 
converted to mzXML format using mzWiff v.4.2.1 
before importing them into the software tools.  
Analysis of the two groups of LC-MS datasets by 
Progenesis LC-MS detected 1,317 features. We used 
Progenesis LC-MS to identify features that are 
differentially abundant between the two groups of 
samples (serum samples mixed with spike-in peptides 
and serum samples alone). After applying correction 
for multiple testing, six features were found to be 
significantly different between the two groups (q-value 
<0.05). In addition to the workflow for difference 
detection, Progenesis LC-MS allows peptide 
identification by analysis of MS/MS data. We used the 
selected six features for peptide identification. Five 
features were identified as MassPrep peptides whereas 
one feature was identified as EVKSADR from 
kininogen protein (P08934). This was the only false 
positive detected by Progenesis LC-MS. Three other 
features that matched m/z and retention time values for 
the spike-in Peptides 1, 6 and 7 but were not detected 
in the first run of analysis. Manual addition to analysis 
resulted in correct identification of these peaks as 
RGDSPASSKP, DRVYIHPFHLLVYS, and 
WLTGPQLADLYHSLMK with a high MASCOT 
score. Figure 2 depicts the three-dimensional LC-MS 
maps zoomed into each of the eight features whose m/z 
and retention time values match with those of the 
MassPrep peptides. All features were correctly 
identified as MassPrep peptides with a high MASCOT 
score, except Peptides 8 and 9 for which no matching 
features were found. 
For XCMS, the challenge was to correctly assign 
features across the multiple runs. By examining 
various peak profiles, we found the following 
parameters that worked best: fwhm = 30, snthresh = 40 
for peak detection, and bw = 60, mzwid = 1.2 and bw = 
40, mzwid = 0.5 for peak grouping in between 
retention time correction. With these parameters, 2,751 
features were detected that were analyzed for 
difference detection. Out of the 2,751 features, 1,642 
were significantly different between the two groups (q-
value < 0.05).  Although most of the 1,642 had a fold 
change < 2, a significant number of features (318) had 
a fold change > 2 and 106 features yielded a fold 




Fig. 2. Three dimensional maps of MassPrep peptides 
analyzed by Progenesis LC-MS. Comparison between 
serum with spike-in peptides (+MassPrep) and serum 
alone (-MassPrep) groups. 
 
For MZmine 2, a span range of m/z = 0.05 Da, 
retention time = 1.5 minute, and presence across a 
minimum of five runs were selected for peak detection 
and filtering purposes. With these parameters, MZmine 
2 detected 1,045 features were detected. Of these, 151 
were significantly different between the two groups (q-
value < 0.05). While 86 features had a fold change > 2, 
only 39 features yielded a fold change > 5. 
Table 1 presents the ranks, p-values, q-values, and 
fold change for the spike-in peptides, obtained by 
comparing the LC-MS data from the two groups using 
the three software tools. Ranking of the peptides was 
done on the basis of q-values. 
All workflows detected significant differences for 
Peptides 2-5, while Peptides 6-9 were consistently 
missing in all. Considering that we expect only the 
MassPrep peptides (Peptides 1-9) to be differentially 
abundant between the two groups of samples, 
Progenesis had only one false positive, while XCMS 
had the largest number of false positives in comparison 
to the other two tools. Since the feature-based 
alignment approach is applied in each of the three 
software tools, it was straightforward to proceed with 
the alignment once peak detection and peak grouping 
were well done. However, feature-based alignment 
methods involve a trade-off between sensitivity (peak 
detection) and specificity (peak grouping) which is 
crucial to the alignment result. To get rid of noisy 
peaks, it is common to apply criteria regarding 
intensity and span range (available in the three 
software tools). For low-abundance peptides, more 
rigorous ways of considering peptide characteristics 
are desired. 
 
Table 1. Rank, p-value, q-value, and fold change of 
spike-in peptides in comparing spike-in serum samples 
versus serum samples alone using Progenesis LC-MS, 






Based on MS/MS search results, we located regions 
of interest for LC-MS runs at MS1 level and examined 
the peak profiles of the MassPrep peptides. Intensities 
of differentially expressed peptides, such as Peptides 2, 
3, 4, and 5 are more than ten times higher than Peptides 
1, 6, and 7. We may include the low-abundance ones 
into analysis by decreasing the threshold for intensity 
or signal-to-noise ratio to a certain amount. However, a 
huge number of peaks (two times more) would also be 
detected and many of them around the low-abundance 
peaks. Since XCMS does not provide specific pipelines 
for further filtering the detected peaks, irrelevant peaks 
would inevitably be included. This consequently 
results in wrong estimation of peak information and 
ambiguous difference detection. Even with a 
conservative way for peak detection, the number of 
irrelevant features is still much higher in XCMS than 
Progenesis LC-MS and MZmine 2. The latter two 




 We present a spike-in experiment to evaluate the 
performance of three software tools in detecting 
differentially abundant peptides by a label-free LC-MS 
method. The performance of each tool is assessed by 
the ability to detect and pick spike-in peptides as 
differences between groups. Tools that accurately 
identify the spike-in peptides are likely to be useful in 
biomarker discovery research.  
 We observe that selection of the appropriate 
parameters in using each software tool is very 
important. Also, to assess the parameters for each 
pipeline explicitly, modular workflows are desired. 
From our study, it is evident that the identification of 
charge states and isotopic patterns greatly reduces 
irrelevant features and is crucial to improve the 
performance of a tool in difference detection. 
 All tools resulted in picking up only four out of 
nine spike-in peptides. Progenesis LC-MS led to the 
least number of false positives and the best ranking and 
statistical significance of the selected features. 
Although Progenesis LC-MS supports a complete 
pipeline for label-free proteomics and provides 
information on conflicting peptides identified for the 
same feature, certain parameters for peak grouping are 
not available for tuning. While XCMS and MZmine 2 
provide the flexibility for software parameterization 
and extended analysis, they lack an identification 
module.  
 Our analysis also highlighted the problem of 
optimal intensity threshold used for complex mixtures 
of peptide. We observed that by reducing the intensity 
threshold, three spike-in peaks that were earlier not 
detected could now be included in the analysis. 
However, this alone will increase the number of 
extracted features that affects peak grouping.  
 The LC-MS data from our spike-in experiment can 
be used as a benchmark for developing and optimizing 
LC-MS data preprocessing algorithms and to evaluate 
workflows implemented in existing software tools.  
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